UVADEX 20 Mikrogramm/ml Lösung zur Modifikation einer Blutfraktion clinical trials

Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steriod-refractory immune related adverse events after immune checkpoint inhibitor therapy - ECIR

This study is looking at a treatment called Extracorporeal Photopheresis (ECP) for people who have developed side effects from certain cancer medicines. It aims to see how safe ECP is and if it helps with problems like gut inflammation, lung inflammation, liver inflammation, or skin rashes.